JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanfelippo, P. M.
Right arrow Articles by McGoon, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanfelippo, P. M.
Right arrow Articles by McGoon, D. C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 71, 441-445, Copyright © 1976 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Tricuspid valve prosthetic replacement. Early and late results with the Starr-Edwards prosthesis

PM Sanfelippo, ER Giuliani, GK Danielson, RB Wallace, JR Pluth and DC McGoon

The total experience (154 patients) with ball-valve (Starr-Edwards) replacement of the tricuspid valve, alone and in combination, through Dec. 31, 1971, at the Mayo Clinic is reviewed. The early mortality rate with isolated tricuspid replacement was twice that for tricuspid replacement combined with replacement of other valves. Among patients receiving three valves, those with "functional'' tricuspid insufficiency and those who were in New York Heart Association (N.Y.H.A.) Class IV preoperatively had a higher early mortality rate. The early mortality rate for the total group was 28%. Of those surviving tricuspid plus mitral valve replacement, 70% were alive at 3 years; at latest follow-up, 94% of those surviving were functionally improved. Of those surviving triple valve replacement, 56% were alive at 3 years; at latest follow-up, 93% of those surviving were functionally improved. Previous cardiac surgery with residual tricuspid valve dysfunction and severe disability, as judged by N.Y.H.A. class, influenced the outcome adversely. The experience reported here provides a standard against which never prostheses can be compared.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. Lee and B.-C. Chang
Reply
Ann. Thorac. Surg., October 1, 2007; 84(4): 1425 - 1425.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B.-C. Chang, S.-H. Lim, G. Yi, Y. S. Hong, S. Lee, K.-J. Yoo, M. S. Kang, and B. K. Cho
Long-Term Clinical Results of Tricuspid Valve Replacement
Ann. Thorac. Surg., April 1, 2006; 81(4): 1317 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. A. Mangoni, T. G. DiSalvo, G. J. Vlahakes, C. A. Polanczyk, and M. A. Fifer
Outcome following isolated tricuspid valve replacement
Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 68 - 73.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. P. Ratnatunga, M.-B. Edwards, C. J. Dore, and K. M. Taylor
Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prostheses
Ann. Thorac. Surg., December 1, 1998; 66(6): 1940 - 1947.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. T. Bajzer, W. J. Stewart, D. M. Cosgrove, S. J. Azzam, K. L. Arheart, and A. L. Klein
Tricuspid valve surgery and intraoperative echocardiography: Factors affecting survival, clinical outcome, and echocardiographic success
J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1023 - 1031.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. M. Reddy, D. B. McElhinney, M. M. Brook, N. H. Silverman, P. Stanger, and F. L. Hanley
Repair of congenital tricuspid valve abnormalities with artificial chordae tendineae
Ann. Thorac. Surg., July 1, 1998; 66(1): 172 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. J. Van Nooten, F. Caes, Y. Taeymans, Y. Van Belleghem, K. Francois, D. De Bacquer, F. E. Deuvaert, F. Wellens, and G. Primo
Tricuspid valve replacement: Postoperative and long-term results
J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 672 - 679.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Nakano, H. Koyanagi, A. Hashimoto, G. Ohtsuka, and C. Nojiri
Tricuspid valve replacement with the bileaflet St. Jude Medical valve prosthesis
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 888 - 892.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1976 by The American Association for Thoracic Surgery.